China Health Group Inc. (FRA:VNL1)

Germany flag Germany · Delayed Price · Currency is EUR
0.0050
0.00 (0.00%)
Last updated: Apr 24, 2026, 3:25 PM CET
Market Cap14.86M -31.6%
Revenue (ttm)3.48M +8.0%
Net Income-1.82M
EPS-0.00
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0050
Previous Close0.0050
Day's Range0.0050 - 0.0050
52-Week Range0.0045 - 0.0300
Betan/a
RSI47.03
Earnings DateMar 30, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar... [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 32
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol VNL1

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY Financial Statements